Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part I

Am Heart J. 1991 Jan;121(1 Pt 1):220-44. doi: 10.1016/0002-8703(91)90986-r.
No abstract available

Publication types

  • Guideline
  • Review

MeSH terms

  • Aged
  • Amino Acid Sequence
  • Angioplasty, Balloon, Coronary
  • Combined Modality Therapy
  • Fibrinolysis / drug effects
  • Hemorrhage / chemically induced
  • Hemostasis / drug effects
  • Humans
  • Molecular Sequence Data
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / mortality
  • Myocardial Infarction / physiopathology
  • Myocardial Reperfusion
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Structure-Activity Relationship
  • Thrombolytic Therapy*
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / adverse effects
  • Tissue Plasminogen Activator / therapeutic use*
  • Ventricular Function, Left / drug effects

Substances

  • Recombinant Proteins
  • Tissue Plasminogen Activator